Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00361348
What this trial is testing

Palifermin DDI (Drug Drug Interaction)

Who this might be right for
Healthy Volunteers
Swedish Orphan Biovitrum 45
Early research (Phase 1)Study completedNCT02171455
What this trial is testing

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 10
Early research (Phase 1)Study completedNCT02144285
What this trial is testing

LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Eli Lilly and Company 64
Testing effectiveness (Phase 2)Looking for participantsNCT07498725
What this trial is testing

Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

Who this might be right for
Neoplasms
LARKSPUR BIOSCIENCES, INC. 120
Early research (Phase 1)UnknownNCT05740917
What this trial is testing

To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS

Who this might be right for
AMLMDS
Xuanzhu Biopharmaceutical Co., Ltd. 82
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Study completedNCT00399438
What this trial is testing

BMS-562086 in Patients With Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Bristol-Myers Squibb 39
Early research (Phase 1)Study completedNCT03976115
What this trial is testing

Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Jiangsu HengRui Medicine Co., Ltd. 54
Early research (Phase 1)Study completedNCT01396252
What this trial is testing

Japanese Phase 1 Multiple Ascending Dose (MAD) Study

Who this might be right for
Depression
Bristol-Myers Squibb 57
Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Early research (Phase 1)Study completedNCT06619392
What this trial is testing

A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects

Who this might be right for
Pain
Shandong Suncadia Medicine Co., Ltd. 44
Early research (Phase 1)Study completedNCT04005807
What this trial is testing

Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults

Who this might be right for
Healthy Volunteers
Belite Bio, Inc 40
Early research (Phase 1)Study completedNCT02534636
What this trial is testing

Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

Who this might be right for
Healthy Subjects
Bristol-Myers Squibb 140
Testing effectiveness (Phase 2)Ended earlyNCT02584634
What this trial is testing

Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 43
Early research (Phase 1)Ended earlyNCT07016464
What this trial is testing

Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.

Who this might be right for
Healthy
reMYND 19
Testing effectiveness (Phase 2)Study completedNCT02598583
What this trial is testing

Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
PNH
Alexion Pharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT00535522
What this trial is testing

A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer

Who this might be right for
Cancer
Millennium Pharmaceuticals, Inc. 56
Early research (Phase 1)UnknownNCT04958772
What this trial is testing

Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers

Who this might be right for
Healthy
Megalabs 100
Early research (Phase 1)Study completedNCT02763839
What this trial is testing

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 19
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Next Page